Claro Advisors’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-10,710
Closed -$157K 421
2023
Q4
$157K Sell
10,710
-972
-8% -$13.6K 0.03% 377
2023
Q3
$168K Buy
11,682
+16
+0.1% +$249 0.04% 355
2023
Q2
$192K Sell
11,666
-835
-7% -$13.6K 0.05% 355
2023
Q1
$209K Buy
12,501
+844
+7% +$13.6K 0.06% 318
2022
Q4
$180K Buy
11,657
+180
+2% +$2.79K 0.06% 292
2022
Q3
$189K Hold
11,477
0.08% 251
2022
Q2
$189K Buy
+11,477
New +$197K 0.08% 251
2022
Q1
Sell
-8,725
Closed -$221K 285
2021
Q4
$221K Buy
+8,725
New +$225K 0.08% 247

Other funds holding BMEZ

Claro Advisors's BMEZ Position: Q1 2024 in Review

Claro Advisors sold out of BlackRock Health Sciences Trust II (BMEZ) in Q1 2024, closing a stake of 10,710 shares — an estimated $157K sold.

Claro Advisors first reported a position in BMEZ in Q4 2021 and held it in 8 quarters. The position peaked at $221K in Q4 2021. 99 funds tracked by Wall St. Rank hold BMEZ as of Q1 2024.

  • Claro Advisors reported no remaining BlackRock Health Sciences Trust II position as of Q1 2024 after selling out during the quarter.
  • Claro Advisors sold 10,710 BlackRock Health Sciences Trust II shares in Q1 2024, an estimated $157K.
  • Claro Advisors first reported a position in BlackRock Health Sciences Trust II in Q4 2021 and held it in 8 quarters.
  • Claro Advisors's BlackRock Health Sciences Trust II position peaked at $221K in Q4 2021.
  • 99 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q1 2024.

Based on Claro Advisors's 13F filing for Q1 2024, filed 18 Apr 2024.